June 17, 2025
RA Jainee
ITI Pharma and Healthcare Fund details, NAV, Portfolio, Returns, Peer Comparison, Fund Managers & Guidance by sahifund.com
NAV Growth: Rs 17.6320
NAV IDCW: Rs 17.6320
Suitable For Which Investors?
This is a fund that invests mainly in shares of pharmaceutical and healthcare companies.
We believe that investors should avoid funds that have a narrowly defined investment mandate such as this one. Instead, they should invest in flexi-cap funds which provide complete freedom to the fund management team to invest in companies from which it expects maximum gains.
But if you do invest, you must do so only through the SIP route.
Fund’s Investment Strategy:
The scheme seeks to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare.
Fund Manager:
1) Rohan Korde
Education: Mr. Korde is a Masters in Management Studies (Finance), Bachelor of Commerce
Experience: Prior to joining ITI Mutual Fund, he has worked with BOB Capital Markets as Vice President
2) Dhimant Shah
Education: Mr. Shah is a B.Com (H) and Chartered Accountant.
Experience: Prior to joining ITI Mutual Fund, he has worked with Principal Mutual Fund, HSBC AMC, Reliance Mutual Fund, ASK Raymond James Securities Pvt. Ltd. and IL&FS AMC. Senior Analyst from April 1997 to August 2003.
Investment Details
| Min. Investment (Rs) | 5,000 |
| Min. Addl Investment (Rs) | 1,000 |
| Min. SIP Investment (Rs) | 500 |
| Min. Withdrawal (Rs) | 1,000 |
| Min. No of Cheques | 12 |
| Min. Balance (Rs) | — |
| Lock-in Period | NA |
| Exit Load | 0.5% for redemption within 3 months |
Basic Details of ITI Pharma and Healthcare Fund
| Fund House | ITI Mutual Fund |
| Launch Date | 08-Nov-21 |
| Return Since Launch | 17.03% |
| Benchmark | NIFTY Healthcare TRI. |
| Riskometer | Very High |
| Type | Open-ended |
| Assets | Rs 221 Cr |
| (As on 31-May-2025) | |
| Expense | 0.47% |
| (As on 31-May-2025) | |
| Risk Grade | Average |
| Return Grade | Average |
| Turnover | 57.00% |
Trailing Returns (%) of ITI Pharma and Healthcare Fund
| Fund name | YTD | 1D | 1M | 3M | 6M | 1Y | 3Y | 5Y | 7Y | 10Y |
| ITI Pharma and Healthcare Dir | -5.18 | 0.60 | 2.63 | 10.97 | -3.27 | 18.15 | 26.91 | — | — | — |
| BSE Healthcare TRI | -2.24 | 0.41 | 4.11 | 12.46 | 0.26 | 18.96 | 28.22 | — | — | — |
| Equity: Sectoral-Pharma | -3.05 | 0.45 | 3.41 | 10.87 | -0.41 | 17.29 | 27.06 | — | — | — |
| Rank within category | 18 | 6 | 15 | 12 | 18 | 7 | 7 | — | — | — |
| Number of funds in category | 21 | 21 | 21 | 21 | 20 | 17 | 11 | 9 | 4 | 3 |
Peer Comparison of ITI Pharma and Healthcare Fund
| Rating | 1 Year Returns | 3 Year Returns | 5 Year Returns | Expense Ratio (%) | Net Assets (Rs Cr) | Return Since Launch (%) | Exit Load (Days) | Fund Age | Turnover (%) | |
| ITI Pharma and Healthcare Dir | 3 star | 18.15 | 26.91 | — | 0.47 | 221 | 17.03 | 0.50 (90) | 3Y 7M | 57.00 |
| ICICI Pru Pharma Healthcare and Diagnostics Dir | 4 star | 22.84 | 31.56 | 26.01 | 1.06 | 5,508 | 23.23 | 1.00 (15) | 6Y 11M | 75.00 |
| SBI Healthcare Opportunities Dir | 5 star | 20.21 | 31.00 | 25.52 | 0.90 | 3,689 | 18.33 | 0.50 (15) | 12Y 5M | 23.00 |
| DSP Healthcare Dir | 4 star | 17.13 | 28.67 | 24.94 | 0.62 | 2,961 | 24.76 | 0.50 (30) | 6Y 6M | 22.00 |
| Tata India Pharma & Healthcare Dir | 4 star | 15.30 | 27.42 | 23.51 | 0.63 | 1,232 | 14.11 | 0.25 (30) | 9Y 5M | 13.77 |
Portfolio Analysis of ITI Pharma and Healthcare Fund
| No. of Stocks | 39 |
| Top 10 Stocks | 59.18% |
| Top 5 Stocks | 40.31% |
| Top 3 Sectors | 98.77% |
| Portfolio P/B Ratio | 5.84 |
| Portfolio P/E Ratio | 30.22 |
Portfolio Breakup
| Fund | Category | |
| Average Mkt Cap (Rs Cr) | 66,959 | 76,989 |
| Giant (%) | 24.90 | 23.83 |
| Large (%) | 30.80 | 34.60 |
| Mid (%) | 32.51 | 33.27 |
| Small (%) | 11.78 | 10.44 |
| Tiny (%) | — | 0.08 |
Chanakya’s Mutual Fund Guidance For ITI Pharma and Healthcare Fund
WILL Post Soon
Disclaimer: Mutual fund investments are subject to market risks. Read all scheme related documents carefully
Apply Online: https://investonline.itiamc.com/#/login
>> Post your MF questions @ sahifund.com/ask-me/
>> NFO Guidance:
https://sahifund.com/category/nfos/
Quicklinks